Free Trial

Verona Pharma PLC American Depositary Share (VRNA) Competitors

Verona Pharma PLC American Depositary Share logo
$105.30 +0.30 (+0.29%)
Closing price 04:00 PM Eastern
Extended Trading
$105.17 -0.13 (-0.12%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VRNA vs. ARGX, ONC, BNTX, SMMT, INSM, TEVA, GMAB, RDY, MRNA, and QGEN

Should you be buying Verona Pharma PLC American Depositary Share stock or one of its competitors? The main competitors of Verona Pharma PLC American Depositary Share include argenex (ARGX), BeOne Medicines (ONC), BioNTech (BNTX), Summit Therapeutics (SMMT), Insmed (INSM), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), and Qiagen (QGEN). These companies are all part of the "pharmaceutical products" industry.

Verona Pharma PLC American Depositary Share vs. Its Competitors

argenex (NASDAQ:ARGX) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

In the previous week, argenex had 11 more articles in the media than Verona Pharma PLC American Depositary Share. MarketBeat recorded 21 mentions for argenex and 10 mentions for Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.75 beat argenex's score of 0.38 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
argenex
5 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Verona Pharma PLC American Depositary Share
9 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

argenex has a net margin of 40.20% compared to Verona Pharma PLC American Depositary Share's net margin of 0.00%. argenex's return on equity of 16.15% beat Verona Pharma PLC American Depositary Share's return on equity.

Company Net Margins Return on Equity Return on Assets
argenex40.20% 16.15% 14.33%
Verona Pharma PLC American Depositary Share N/A -69.65%-28.00%

argenex has higher revenue and earnings than Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than argenex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
argenex$2.25B16.09$833.04M$16.2136.52
Verona Pharma PLC American Depositary Share$42.28M212.02-$173.42M-$2.00-52.65

argenex presently has a consensus price target of $728.06, indicating a potential upside of 22.99%. Verona Pharma PLC American Depositary Share has a consensus price target of $109.00, indicating a potential upside of 3.51%. Given argenex's stronger consensus rating and higher possible upside, research analysts plainly believe argenex is more favorable than Verona Pharma PLC American Depositary Share.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
argenex
0 Sell rating(s)
0 Hold rating(s)
19 Buy rating(s)
2 Strong Buy rating(s)
3.10
Verona Pharma PLC American Depositary Share
0 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.15

argenex has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500.

60.3% of argenex shares are owned by institutional investors. Comparatively, 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. 2.4% of argenex shares are owned by insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

argenex beats Verona Pharma PLC American Depositary Share on 13 of the 17 factors compared between the two stocks.

Get Verona Pharma PLC American Depositary Share News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VRNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRNA vs. The Competition

MetricVerona Pharma PLC American Depositary ShareMED IndustryMedical SectorNASDAQ Exchange
Market Cap$8.94B$3.07B$5.70B$9.51B
Dividend YieldN/A2.36%4.69%4.01%
P/E Ratio-52.6521.0428.0720.05
Price / Sales212.02284.46448.5799.42
Price / CashN/A42.7636.2258.56
Price / Book41.138.378.665.87
Net Income-$173.42M-$55.19M$3.25B$258.55M
7 Day Performance0.38%5.89%4.20%2.23%
1 Month Performance10.71%17.63%10.82%12.76%
1 Year Performance375.40%5.09%34.70%19.36%

Verona Pharma PLC American Depositary Share Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRNA
Verona Pharma PLC American Depositary Share
2.6637 of 5 stars
$105.30
+0.3%
$109.00
+3.5%
+398.3%$8.94B$42.28M-52.6530Positive News
ARGX
argenex
3.6805 of 5 stars
$566.14
+0.3%
$728.06
+28.6%
+27.4%$34.65B$2.25B34.931,599Trending News
Upcoming Earnings
Analyst Revision
ONC
BeOne Medicines
1.2886 of 5 stars
$291.93
-0.9%
$327.56
+12.2%
N/A$32.00B$3.81B-78.4811,000Insider Trade
Gap Down
BNTX
BioNTech
1.4075 of 5 stars
$108.91
-1.0%
$136.58
+25.4%
+37.8%$26.18B$2.98B-32.036,772News Coverage
SMMT
Summit Therapeutics
2.1516 of 5 stars
$26.34
+0.5%
$34.67
+31.6%
+176.3%$19.56B$700K-77.47110Positive News
INSM
Insmed
3.9532 of 5 stars
$102.78
+0.2%
$108.47
+5.5%
+39.1%$19.50B$363.71M-17.271,271Positive News
Analyst Forecast
Insider Trade
TEVA
Teva Pharmaceutical Industries
4.4316 of 5 stars
$16.30
+1.5%
$24.71
+51.7%
-0.8%$18.69B$16.54B-14.1736,830Upcoming Earnings
GMAB
Genmab A/S
4.0706 of 5 stars
$21.70
-0.8%
$37.80
+74.2%
-15.2%$13.92B$3.12B12.332,682Positive News
RDY
Dr. Reddy's Laboratories
2.3286 of 5 stars
$14.57
+0.6%
$16.95
+16.4%
-8.1%$12.16B$3.81B22.0727,811Earnings Report
MRNA
Moderna
4.2501 of 5 stars
$30.97
-0.9%
$46.61
+50.5%
-71.2%$11.98B$3.24B-3.555,800Upcoming Earnings
Analyst Forecast
QGEN
Qiagen
3.7097 of 5 stars
$48.06
-0.6%
$49.40
+2.8%
+25.6%$10.68B$1.98B120.495,765Positive News
Analyst Revision

Related Companies and Tools


This page (NASDAQ:VRNA) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners